Proteomics International Laboratories Ltd.ASX: PIQ

AGM Chair and CEO Address and Presentation

· Issued by Proteomics International Laboratories Ltd. via ASX

Filed with ASX · · 13 pages · English

Summary by 6ix AI

Proteomics International Laboratories Ltd. presented the Chair’s Address and CEO’s presentation at its Annual General Meeting, outlining the company's transition to a commercially-focused diagnostics business. The CEO highlighted the launch of three diagnostic tests and the strategic partnership with Healius to enhance distribution and market access. The company aims to build clinician adoption and revenue while managing funding and operational efficiency.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Release 20 November 2026 ASX code: PIQ 2026 Annual General Meeting Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ), a pioneer in precision diagnostics, is pleased to present the Chair’s Address and Company Presentation to be presented at the...

Proteomics International Laboratories Ltd. on 6ix

In the deck

Story so far

Earlier from Proteomics International Laboratories

Later from Proteomics International Laboratories

All Proteomics International Laboratories news releases